Afford - Sept. 27, 2022

DAVE:

Drug companies have doubled the cost of insulin on us.

Now they’re spending millions the elect Tyler Kistner. He opposes capping insulin costs.

And he opposes medicare negotiating for lower drug prices.

They can afford Tyler Kistner - but we sure can’t.